The Seena Magowitz Foundation To Honor Ron Brefka Through The “Harley Hero” Award at the Harley Davidson Museum Brefka, an avid Harley Davidson fan, raised thousands of dollars for various
‘Baseball for Babbo’ Raises $153,868 For Pancreatic Cancer Research 100% of Proceeds From Babbo’s Day of Giving Was Donated to the Seena Magowitz Foundation PHOENIX, AZ — It was a grand slam
FOR IMMEDIATE RELEASE Media Contact: Miranda Landsman Phone: 936-615-0753 Email: miranda@seenamagowitzfoundation.org Roger E. Magowitz Receives Award Lifetime Bedding Achievement from Furniture Today March 2022 – For his tireless work
“A Clinical Trial of One”: Art Levine’s Story Written By Julia Brabant August 2021 Diagnosed: May 2019 Current Status: Continuing Treatment Every pancreatic cancer case is different, and a treatment
RABL3 Inherited Pancreatic Cancer Risk Mutation Identified Original Source Dana-Farber Cancer Institute Modified For Style and Length This article originally appeared at the Dana-Farber Cancer Institute Scientists at the Dana-Farber
New TGen Study To Combat Pancreatic Cancer The Seena Magowitz Foundation Releases $200,000 Toward A Total Grant of $1 Million To Fund The Study The Translational Genomics Research Institute (TGen), an
Scientists At Purdue University Reverse Pancreatic Cancer Progression In A “Time Machine” Made of Human Cells Purdue University Engineers Have Shown A Novel Way To Reverse The Course of
Voice of Pancreatic Cancer Podcast MAY 1, 2021 EPISODE: “The PANCREAS Clinical Trial” The PANCREAS Clinical Trial was officially launched by the LaBahn Pancreatic Cancer Program at the Medical College
Announcing The Launch of “THE PANCREAS Clinical Trial” The “PANCREAS” Clinical Trial By the Medical College of Wisconsin and Partly Funded By The Seena Magowitz Foundation Contribting Writer Tony Subia
Every Pancreatic Cancer Patient Should Consider Genetic Testing Contributing Writer Tony Subia February 22, 2021 Cancer which include pancreatic cancer is caused by genetic mutations. Each cell in your body
Combining CRP and CA19-9 in A Prognostic Score in PDAC Original Article: https://www.nature.com/articles/s41598-020-80778-0 Download PDF Helsinki University Hospital January 12, 2021 Creative Commons Attribution
New Biomarker May Predict Which Patients Respond To CD40 Source: Penn Medicine Abramson Cancer Center News Release: February 4, 2021 Modified For Style and Length By The Seena Magowitz Foundation